课题基金 / 基金详情

Renin angiotensin system and connexin43

Renin angiotensin system and connexin43
肾素血管紧张素系统和连接蛋白43
批准号:
7931573
负责人:
SAMUEL C DUDLEY
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-10-01 至 2014-09-30
关键词:
AddressAdmission activityAmericanAmino AcidsAngiotensin IAngiotensin IIAngiotensin ReceptorAngiotensin-Converting Enzyme InhibitorsArrhythmiaAscorbic AcidAtrial FibrillationBiological AvailabilityBiological MarkersBlood PressureCanis familiarisCardiacCardiovascular systemCessation of lifeCleaved cellClinicalConnexin 43ConnexinsCoronary Artery BypassCouplingDataDefectElectric StimulationEnzyme InhibitionEventFamily suidaeGenerationsGlutathione DisulfideHealthcareHeartHeart AtriumHeart DiseasesHeart failureHospitalsHumanHydrogen PeroxideHydroxyl RadicalHypertensionIncidenceInterventionIon ChannelKnockout MiceLeadLeftLinkLipid PeroxidationMeasuresMediatingMediator of activation proteinMessenger RNAModelingMusNADPH OxidaseNitric OxideNodalOxidation-ReductionOxidative StressPathologyPatientsPeptidesPeptidyl-Dipeptidase APerformancePericardial effusionPeroxonitritePhenotypePostoperative PeriodPredispositionProceduresProductionProteinsPulmonary EdemaReceptor, Angiotensin, Type 1RegulationRelapseRenin-Angiotensin SystemRiskSRC geneShapesSignal PathwaySignal TransductionSignaling MoleculeSolidSudden DeathSuperoxidesSurfaceSystemTestingTissuesUp-RegulationVentricularVentricular ArrhythmiaVentricular TachycardiaVeteransabstractingactivating transcription factorascorbatebasehuman NOS3 proteinimprovedinhibitor/antagonistinsightmortalitymouse modelnitrationnovelnovel diagnosticsnovel therapeutic interventionoverexpressionoxidant stressoxidationoxidized lipidpreventprospectivetherapy developmenttoolvoltage

项目摘要

项目成果

SAMUEL C DUDLEY的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Project abstract. Activation of the renin-angiotensin system (RAS) system is associated with increased cardiovascular death. A critical component of this system is angiotensin converting enzyme (ACE), which cleaves the decapeptide angiotensin I, producing the eight amino acid peptide angiotensin II (AngII), a central signaling molecule of the RAS system. In humans, increased AngII levels are associated with an increased ventricular arrhythmic risk, and use of ACE inhibitors reduces that risk. To investigate RAS induced arrhythmias, we developed a cardiac-restricted ACE overexpression mouse that shows an increased risk of sudden death in the absence of heart failure or structural heart disease. In this application, we show that AngII- mediated oxidative stress activates the transcription factor NFkB via H2O2 production, c-Src is transcriptionally upregulated in our model, and ACE mice have reduced Cx43 protein in the absence of changes in mRNA abundance. Therefore, we will test to what extent AngII leads to oxidative stress which in-turn alters Cx43, contributing to the ACE 8/8 arrhythmic phenotype. This will be tested in 4 aims. In each aim, we will establish to what extent measures of oxidative stress, NFB, c-Src, Cx43, and arrhythmic risk are altered by the disruptions in the proposed signaling cascade. The aims are constructed to test a specific, plausible signaling cascade and simultaneously establish the order of the intermediates in the cascade. Specific aim 1: To establish to what extent AngII-mediated signaling is responsible for the Cx43 regulation in our ACE overexpression model. Specific aim 2: To establish to what extent NADPH oxidase activation is responsible for the Cx43 regulation in our ACE overexpression model. Specific aim 3: To establish to what extent increased NFkB activation is responsible for the Cx43 regulation in our ACE overexpression model. Specific aim 4: To establish to what extent increased c-Src upregulation is responsible for the Cx43 regulation in our ACE overexpression model. PUBLIC HEALTH RELEVANCE: Potential Impact to Veterans Health Care. Heart failure is one of the most common causes of hospital admission and death in veterans and all Americans. Inhibiting angiotensin II signaling in heart failure has improved mortality by reducing sudden and non-sudden death. This project will address an important clinical problem of how do angiotensin II inhibitors reduce sudden death risk. This is likely to lead to new insights into how sudden death risk is incurred in conditions of reduced cardiac function. Specifically, this application will give a more complete picture of the pro-arrhythmic effects of AngII on heart, which could lead to new diagnostic and therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Resolution of inflammation and atrial fibrillation
  • 批准号:
    10679718
  • 项目类别:
  • 资助金额:
    $73.33万
  • 财政年份:
    2023
  • 负责人:
    SAMUEL C DUDLEY
  • 依托单位:
Magnesium, mitochondria, and diastolic dysfunction
  • 批准号:
    10705354
  • 项目类别:
  • 资助金额:
    $54.44万
  • 财政年份:
    2022
  • 负责人:
    SAMUEL C DUDLEY
  • 依托单位:
Unfolded Protein Response and Arrhythmias
  • 批准号:
    9977253
  • 项目类别:
  • 资助金额:
    $47.01万
  • 财政年份:
    2017
  • 负责人:
    SAMUEL C DUDLEY
  • 依托单位:
A blood test to predict sudden death risk
  • 批准号:
    8392935
  • 项目类别:
  • 资助金额:
    $26.98万
  • 财政年份:
    2012
  • 负责人:
    SAMUEL C DUDLEY
  • 依托单位: